Etomoxir sodium salt

Cat. No.: OB0225WX-2739

Appearance: Solid

Purity: ≥99%

Identity: Confirmed by NMR, and HPLC.

Size:

INQUIRY Datasheet MSDS

Add to basket

Product Overview

Description: Etomoxir sodium salt acts as an irreversible inhibitor of carnitine palmitoyltransferase-1 (CPT-1) located on the mitochondrial membrane and is known to enhance palmitate-induced apoptosis.

Synonym: (R)-(+)-Etomoxir sodium salt; 828934-41-4; (R)-(+)-Etomoxir sodium salt; Etomoxir sodium salt; Etomoxir sodium; (+)-Etomoxir sodium salt; Etomoxir free acid sodium; Sodium (R)-2-(6-(4-chlorophenoxy)hexyl)oxirane-2-carboxylate; Etomoxir (sodium salt); R-(+)-Etomoxir free acid sodium; Sodium (2R)-2-[6-(4-chlorophenoxy)hexyl]oxirane-2-carboxylate; sodium;(2R)-2-[6-(4-chlorophenoxy)hexyl]oxirane-2-carboxylate; (2R)-2-[6-(4-chlorophenoxy)hexyl]-2-oxiranecarboxylic acid monosodium salt; 2-Oxiranecarboxylic acid, 2-(6-(4-chlorophenoxy)hexyl)-, sodium salt (1:1), (2R)-; (2R)-2-[6-(4-Chlorophenoxy)hexyl]-oxiranecarboxylic Acid Sodium Salt; Etomoxir (+) Na; MFCD07787411; Sodium(R)-2-(6-(4-chlorophenoxy)hexyl)oxirane-2-carboxylate; R(+)-2-[6-(4-Chlorophenoxy)hexyl]-oxirane-2-carboxylic acid sodium salt

CAS No.: 828934-41-4

Compound CID: 57345784

Formula: C₁₅H₁₈ClO₄·Na

Formula Weight: 320.74

Specification

Stability: 3 years in powder form.

Storage: Storage at -20°C.

Applications: Etomoxir sodium salt is utilized in metabolic research as a potent inhibitor of carnitine palmitoyltransferase 1 (CPT1) to investigate the regulation of long-chain fatty acid oxidation and cellular energy preference.